The talkgreen trial, led by a well-known company, aims to examine the effects of a premium hormone-regulating supplement on menopause symptoms for 550 participants. The trial, which starts on 5th January 2025, will last 90 days and is scheduled for early January. Participants will be required to complete five short questionnaires about their well-being throughout the study.
Those who complete the study will have the opportunity to receive an additional month's supply of the premium supplement, a 50% discount code for three months, and entry into a prize draw to win one of ten bundles of goodies from the company.
The key dates for this trial are as follows:
- Monday 6th January: Eligible participants will receive an email from talkhealth.
- Wednesday 8th to 10th January: Participants will receive the first questionnaire and supplement.
- Monday 13th January: Participants are asked to start taking the supplement.
The purpose of this trial is to investigate the effects of the premium supplement on menopause symptoms and well-being. The study provides an excellent opportunity for participants to potentially improve their quality of life during this challenging time in their lives.
